Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42

详细信息    查看全文

• 作者：Tian Yang (1)
  Tianjun Chen (1)
  Yang Li (1)
  Lei Gao (1)
  Shuo Zhang (1)
  Ting Wang (1)
  Mingwei Chen (1)
  
  1. Department of Respiratory Medicine ; The First Affiliated Hospital ; College of Medicine ; Xi鈥檃n Jiaotong University ; 277 West Yanta Road ; Xi鈥檃n ; 710061 ; China
  
• 关键词：NSCLC ; A549 ; Mir ; 25 ; CDC42
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：36
• 期：3
• 页码：1903-1911
• 全文大小：816 KB
• 参考文献：1. Siegel, R, Naishadham, D, Jemal, A (2012) Cancer statistics, 2012. CA: A Cancer J Clin 62: pp. 10-29
  2. Rivera, MP (2004) Multimodality therapy in the treatment of lung cancer. Semin Respir Crit Care Med 25: pp. 3-10 829639" target="_blank" title="It opens in new window">CrossRef
  3. Lewis, BP, Burge, CB, Bartel, DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: pp. 15-20 CrossRef
  4. Pillai, RS (2005) MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 11: pp. 1753-61 8605" target="_blank" title="It opens in new window">CrossRef
  5. Kumar, MS, Lu, J, Mercer, KL, Golub, TR, Jacks, T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: pp. 673-7 8/ng2003" target="_blank" title="It opens in new window">CrossRef
  6. He, L, Thomson, JM, Hemann, MT, Hernando-Monge, E, Mu, D, Goodson, S (2005) A microRNA polycistron as a potential human oncogene. Nature 435: pp. 828-33 8/nature03552" target="_blank" title="It opens in new window">CrossRef
  7. Hwang, HW, Mendell, JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: pp. 776-80 8/sj.bjc.6603023" target="_blank" title="It opens in new window">CrossRef
  8. Garzon, R, Calin, GA, Croce, CM (2009) MicroRNAs in cancer. Annu Rev Med 60: pp. 167-79 CrossRef
  9. Lynam-Lennon, N, Maher, SG, Reynolds, JV (2009) The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84: pp. 55-71 85X.2008.00061.x" target="_blank" title="It opens in new window">CrossRef
  10. Wang, Y, Lee, CG (2009) MicroRNA and cancer鈥攆ocus on apoptosis. J Cell Mol Med 13: pp. 12-23 82-4934.2008.00510.x" target="_blank" title="It opens in new window">CrossRef
  11. Ma, J, Dong, C, Ji, C (2010) MicroRNA and drug resistance. Cancer Gene Ther 17: pp. 523-31 8/cgt.2010.18" target="_blank" title="It opens in new window">CrossRef
  12. Nordentoft, I, Birkenkamp-Demtroder, K, Agerbaek, M, Theodorescu, D, Ostenfeld, MS, Hartmann, A (2012) MiRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genet 5: pp. 40
  13. Singh, S, Chitkara, D, Kumar, V, Behrman, SW, Mahato, RI (2013) MiRNA profiling in pancreatic cancer and restoration of chemosensitivity. Cancer Lett 334: pp. 211-20 8" target="_blank" title="It opens in new window">CrossRef
  14. Kim, CH, Kim, HK, Rettig, RL, Kim, J, Lee, ET, Aprelikova, O (2011) MiRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genet 4: pp. 79
  15. Zhang, H, Zuo, Z, Lu, X, Wang, L, Wang, H, Zhu, Z (2012) MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 27: pp. 594-8
  16. Smith, AL, Iwanaga, R, Drasin, DJ, Micalizzi, DS, Vartuli, RL, Tan, AC (2012) The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 31: pp. 5162-71 8/onc.2012.11" target="_blank" title="It opens in new window">CrossRef
  17. Li, Y, Tan, W, Neo, TW, Aung, MO, Wasser, S, Lim, SG (2009) Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 100: pp. 1234-42 CrossRef
  18. Tan, W, Li, Y, Lim, SG, Tan, TM (2014) MiR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol: WJG 20: pp. 5962-72 8/wjg.v20.i20.5962" target="_blank" title="It opens in new window">CrossRef
  19. Chen, X, Ba, Y, Ma, L, Cai, X, Yin, Y, Wang, K (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: pp. 997-1006 8/cr.2008.282" target="_blank" title="It opens in new window">CrossRef
  20. Landi, MT, Zhao, Y, Rotunno, M, Koshiol, J, Liu, H, Bergen, AW (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res: off J Am Assoc Cancer Res 16: pp. 430-41 8/1078-0432.CCR-09-1736" target="_blank" title="It opens in new window">CrossRef
  21. Arias-Romero, LE, Chernoff, J (2013) Targeting Cdc42 in cancer. Expert Opin Ther Targets 17: pp. 1263-73 8222.2013.828037" target="_blank" title="It opens in new window">CrossRef
  22. Stengel, K, Zheng, Y (2011) Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal 23: pp. 1415-23 CrossRef
  23. Zhang, JY, Zhang, D, Wang, EH (2013) Overexpression of small GTPases directly correlates with expression of delta-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer. Mol Carcinog 52: pp. 338-47 854" target="_blank" title="It opens in new window">CrossRef
  24. Hua, KT, Tan, CT, Johansson, G, Lee, JM, Yang, PW, Lu, HY (2011) N-alpha-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell 19: pp. 218-31 CrossRef
  25. Olson, MF, Ashworth, A, Hall, A (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: pp. 1270-2 CrossRef
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

The current study aims to investigate the fuctional role of miRNA-25 in non-small cell lung cancer (NSCLC) cells. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-25 in NSCLC cell lines and 11 pairs of human NSCLC and non-cancerous tissues. The inhibitor of miR-25 was stably transfected into NSCLC cell line A549 cells. Then the effects of downregulating miR-25 on cancer cell proliferation, cell cycle arrest, chemosensitivity to cisplatin, and growth of in vivo xenograft were investigated. Direct regulation of miR-25 on its target gene, cell division cycle 42 (CDC42), was examined by luciferase reporter assay, qRT-PCR and western blot. CDC42 was then upregulated in A549 cells to investigate its effect on miR-25-mediated NSCLC cell proliferation and cell cycle arrest. The expression of miR-25 in NSCLC cells or human tissues was significantly higher than that in normal lung cells or adjacent non-cancerous tissues, respectively. Downregulation of miR-25 markedly inhibited A549 cell proliferation, induced G1 cell cycle arrest, increased cisplatin sensitivity, and suppressed the growth of caner cell xenograft in vivo. CDC42 was confirmed to be the directly regulated by miR-25 in A549 cells. Upregulation of CDC42 in A549 cells rescued the inhibitory effect on proliferation and the G1 cell cycle arrest induced by miR-25 downregulation. Our study demonstrates miR-25, by targeting CDC42, is an important regulator in NSCLC.